(Q37883492)

24 August 2017

Vitreous cavity haemorrhage post-vitrectomy for diabetic eye disease: the effect of perioperative anticoagulation and antiplatelet agents (English)

1 reference

24 August 2017

1 reference

1 reference

David C A Fabinyi

1

1 reference

24 August 2017

Evelyn C O'Neill

series ordinal

2

1 reference

24 August 2017

Paul P Connell

series ordinal

3

1 reference

24 August 2017

J Ben Clark

series ordinal

4

1 reference

24 August 2017

14 June 2011

1 reference

Clinical and Experimental Ophthalmology

24 August 2017

1 reference

24 August 2017

39

1 reference

24 August 2017

9

1 reference

24 August 2017

878-884

1 reference

Patients under anti-platelet therapy

24 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02575.X

Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02575.X

Perioperative management of anticoagulated patients having cataract surgery: National audit of current practice of members of the Royal College of Ophthalmologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02575.X

Anticoagulation therapy in glaucoma surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02575.X

Management of the anticoagulated patient for ophthalmic surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02575.X

Aspirin and warfarin therapy in oculoplastic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02575.X

Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02575.X

Anticoagulation with warfarin in vitreoretinal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02575.X

Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02575.X

Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: an ultrasound biomicroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02575.X

The effects of aspirin and warfarin therapy on haemorrhage in vitreoretinal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02575.X

Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic eyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02575.X

Role of residual vitreous cortex removal in prevention of postoperative vitreous hemorrhage in diabetic vitrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02575.X

Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02575.X

Intravitreal Long-Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02575.X

10.1111/J.1442-9071.2011.02575.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference